Metformin as adjuvant therapy to IVF in women with PCOS: When is intention-to-treat unintentional?

Human Reproduction

Volumn 26, Issue 8, 2011, Pages 2043-2044

  Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN; METFORMIN; PLACEBO;

ADJUVANT THERAPY; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; INFERTILITY; INTENTION TO TREAT ANALYSIS; NOTE; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY OUTCOME; PREGNANCY RATE; SYSTEMATIC REVIEW (TOPIC);

EID: 79960551817     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der155     Document Type: Note

References (8)

1. CostelloMF, Chapman M, Conway U.Asystematic reviewand meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 2006;21:1387-1399. (Pubitemid 44445013)
2. Kjotrod SB, von During V, Carlsen SM. Metformin treatment before IVF/ ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 2004;19:1315-1322. (Pubitemid 38807702)
3. Kjøtrød SB, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, Haapaniemi Kouru K, Morin-Papunen L, Humaidan P, Sunde A et al. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomised, double-blind, multicentre study. Hum Reprod 2011.
4. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA et al.: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-566. (Pubitemid 46220816)
5. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010;CD003053.
6. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004;19:1734-1740. (Pubitemid 39144614)
7. Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogoy K, Kleggetveit O, Hjelle S, von Brandis P, Eikeland T, Flo K. et al.: Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448-455.
8. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43:647-654. (Pubitemid 24145474)